ArticleBioengineered2022

Serine hydroxymethyltransferase 2 (SHMT2) potentiates the aggressive process of oral squamous cell carcinoma by binding to interleukin enhancer-binding factor 2 (ILF2).

Hui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.